Skip Nav Destination
Issues
1 April 2002
ISSN 1078-0432
EISSN 1557-3265
Editorial
Minireview
The Biology Behind
Special Article
Advances in Brief
Impact of Prolonged Infusions of the Putative Differentiating Agent Sodium Phenylbutyrate on Myelodysplastic Syndromes and Acute Myeloid Leukemia1
Steven D. Gore; Li-Jun Weng; William D. Figg; Suoping Zhai; Ross C. Donehower; George Dover; Michael R. Grever; Constance Griffin; Louise B. Grochow; Anita Hawkins; Kathleen Burks; Yelena Zabelena; Carole B. Miller
2-[18F]Fluoro-2-deoxyglucose and Glucose Uptake in Malignant Gliomas before and after Radiotherapy: Correlation with Outcome1
Alexander M. Spence; Mark Muzi; Michael M. Graham; Finbarr O’Sullivan; Jeanne M. Link; Thomas K. Lewellen; Barbara Lewellen; Scott D. Freeman; David A. Mankoff; Janet F. Eary; Kenneth A. Krohn
Circulating Epstein-Barr Virus DNA in Serum of Patients with Lymphoepithelioma-like Carcinoma of the Lung: A Potential Surrogate Marker for Monitoring Disease
Roger K. C. Ngan; Timothy T. C. Yip; Wai-Wai Cheng; John K. C. Chan; William C. S. Cho; Victor W. S. Ma; Kwong-Kee Wan; Siu-Kie Au; Chun-Key Law; Wai-Hon Lau
Regular Articles
Clinical Trials
Therapeutic Potential of a Reduced-Intensity Preparative Regimen for Allogeneic Transplantation with Cladribine, Busulfan, and Antithymocyte Globulin against Advanced/Refractory Acute Leukemia/Lymphoma
Takeshi Saito; Yoshinobu Kanda; Masahiro Kami; Kazunori Kato; Nahoko Shoji; Sachiyo Kanai; Toshihiro Ohnishi; Yoshifumi Kawano; Kunihisa Nakai; Toshie Ogasawara; Hiroshi Matsubara; Atsushi Makimoto; Ryuji Tanosaki; Kensei Tobinai; Hiro Wakasugi; Yoichi Takaue; Shin Mineishi
Phase I and Pharmacokinetics Study of Crotoxin (Cytotoxic PLA2, NSC-624244) in Patients with Advanced Cancer1
Jorge E. Cura; Daniel P. Blanzaco; Cecilia Brisson; Marco A. Cura; Rosa Cabrol; Luis Larrateguy; Carlos Mendez; Jose Carlos Sechi; Jorge Solana Silveira; Elvira Theiller; Adolfo R. de Roodt; Juan Carlos Vidal
Phase I Clinical and Pharmacokinetic Study of Protein Kinase C-α Antisense Oligonucleotide ISIS 3521 Administered in Combination with 5-Fluorouracil and Leucovorin in Patients with Advanced Cancer1
Sridhar Mani; Charles M. Rudin; Katie Kunkel; Jon T. Holmlund; Richard S. Geary; Hedy L. Kindler; F. Andrew Dorr; Mark J. Ratain
Cancer Biology, Immunology, Cytokines
Research Articles
Molecular Oncology, Markers, Clinical Correlates
Regulation of Stromal Versican Expression by Breast Cancer Cells and Importance to Relapse-free Survival in Patients with Node-negative Primary Breast Cancer1
Carmela Ricciardelli; John H. Brooks; Supaporn Suwiwat; Andrew J. Sakko; Keiko Mayne; Wendy A. Raymond; Ram Seshadri; Richard G. LeBaron; David J. Horsfall
Quantitative Reverse Transcription-Polymerase Chain Reaction Measurement of HASH1 (ASCL1), a Marker for Small Cell Lung Carcinomas with Neuroendocrine Features1
Bart A. Westerman; Sari Neijenhuis; Ankie Poutsma; Renske D. M. Steenbergen; Roderick H. J. Breuer; Monique Egging; Inge J. van Wijk; Cees B. M. Oudejans
Expression of the Serine Protease Matriptase and Its Inhibitor HAI-1 in Epithelial Ovarian Cancer: Correlation with Clinical Outcome and Tumor Clinicopathological Parameters1
Michael D. Oberst; Michael D. Johnson; Robert B. Dickson; Chen-Yong Lin; Baljit Singh; Moira Stewart; Alastair Williams; Awatif al-Nafussi; John F. Smyth; Hani Gabra; Grant C. Sellar
Expressions of Cyclooxygenase-2 and Prostaglandin E-Receptors in Carcinoma of the Gallbladder: Crucial Role of Arachidonate Metabolism in Tumor Growth and Progression1
Toru Asano; Junichi Shoda; Tetsuya Ueda; Toru Kawamoto; Takeshi Todoroki; Manabu Shimonishi; Tadashi Tanabe; Yukihiko Sugimoto; Atsushi Ichikawa; Michihiro Mutoh; Naomi Tanaka; Masanao Miwa
Experimental Therapeutics, Preclinical Pharmacology
Antiangiogenic and Antitumor Activity of IDN 5390, a New Taxane Derivative1
Giulia Taraboletti; Gianluca Micheletti; Monica Rieppi; Maura Poli; Michele Turatto; Cosmo Rossi; Patrizia Borsotti; Paola Roccabianca; Eugenio Scanziani; Maria Ines Nicoletti; Ezio Bombardelli; Paolo Morazzoni; Antonella Riva; Raffaella Giavazzi
The Antiangiogenic Agent Neovastat (Æ-941) Inhibits Vascular Endothelial Growth Factor-mediated Biological Effects1
Richard Béliveau; Denis Gingras; Erwin A. Kruger; Sylvie Lamy; Pierre Sirois; Bryan Simard; Martin G. Sirois; Leone Tranqui; Fabienne Baffert; Édith Beaulieu; Violetta Dimitriadou; Marie-Claude Pépin; Frank Courjal; Isabelle Ricard; Patrick Poyet; Pierre Falardeau; William D. Figg; Éric Dupont
Inhibition of Tumorigenicity and Metastasis of Human Bladder Cancer Growing in Athymic Mice by Interferon-β Gene Therapy Results Partially from Various Antiangiogenic Effects Including Endothelial Cell Apoptosis1
Jonathan I. Izawa; Paul Sweeney; Paul Perrotte; Daniel Kedar; Zhongyun Dong; Joel W. Slaton; Takashi Karashima; Keji Inoue; William F. Benedict; Colin P. N. Dinney
Bcl-2 Antisense Oligonucleotides Are Effective against Systemic but not Central Nervous System Disease in Severe Combined Immunodeficient Mice Bearing Human t(14;18) Follicular Lymphoma1
Ramzi Mohammad; Yousif Abubakr; Maria Dan; Amro Aboukameel; Christine Chow; Anwar Mohamed; Nayera Hamdy; Ayad Al-Katib
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds